MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12882-026-04991-1

Медицинская библиотека · BMC nephrology · 2026

Comparative performance of risk prediction models for kidney disease: an external validation using 0.5 million UK Biobank participants.

Zhang Yikun, Chan Chun Hin, Lam Hin Lai Ivan, Bishai David, Clarke Philip, Tang Sydney C W, Quan Jianchao

СтатьяСравнительное исследованиеВалидационное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To compare the external validation performance of existing kidney disease risk prediction models for the general population, individuals with type 2 diabetes, and across various subgroups. MATERIALS AND

METHODS

We identified and compared 16 risk prediction models for chronic kidney disease (CKD) or kidney failure from 3 recent systematic reviews (7 models for the whole population, 9 models specific for type 2 diabetes). We analysed 497,896 adults (age 38–73) in the UK Biobank data; of which 4·7% (n = 23,298) had type 2 diabetes. Models were evaluated by discrimination and calibration performance with subgroup analyses by age, sex, ethnicity and pre-existing hypertension.

RESULTS

During a total follow-up of 5·95 million person-years (median: 12·2 years; IQR: 1·4), predictive models for people without diabetes exhibited fair-to-excellent discrimination performance (c-indices: 0·695-0·806) but severely overpredicted risk. The O’Seaghdha model demonstrated the best overall performance for discrimination (c-index: 0·806 [0·806-0·807]) and calibration (slope: 0·69, intercept: -0·011; Brier score: 0·03 [0·02,0·04]). Models including medications for diabetes showed superior performance. Discriminative performance was poorer for people with diabetes or hypertension. Severe miscalibration occurred for many models.

CONCLUSION

Most models demonstrated fair to excellent discrimination for CKD and good to excellent discrimination for kidney failure. Calibration performance was frequently suboptimal; most models substantially overpredicted CKD risk while underpredicting kidney failure risk, indicating that recalibration is warranted prior to clinical application. Model performance in individuals with diabetes or hypertension was poorer. Future CKD risk prediction model development should incorporate diabetes medication use to enhance discriminative capability.

Для цитирования: Zhang Yikun, Chan Chun Hin, Lam Hin Lai Ivan, Bishai David, Clarke Philip, Tang Sydney C W, Quan Jianchao. Comparative performance of risk prediction models for kidney disease: an external validation using 0.5 million UK Biobank participants.. BMC nephrology. 2026. DOI: 10.1186/s12882-026-04991-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.